drug development

Still too little progress on antibiotic resistance, says O’Neill report update
Still too little progress on antibiotic resistance, says O’Neill report update
Pharmaforum
antibiotics
antibiotic resistance
drug development
Flag link:
Distorted Drug Patents: Does the U.S. Legal System Steer Researchers Away From Drugs that Take a Long Time to Develop?
Distorted Drug Patents: Does the U.S. Legal System Steer Researchers Away From Drugs that Take a Long Time to Develop?
FDA Law Blog
patents
innovation
drug development
FDA
Flag link:
Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence
Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence
Globe Newswire
Novartis
Microsoft
artificial intelligence
innovation
drug development
Flag link:
Patient-focused drug development: New FDA draft guidance delves into what’s important
Patient-focused drug development: New FDA draft guidance delves into what’s important
Endpoints
FDA
drug development
patients
Flag link:
Researchers Develop New Class of Lung Cancer Drugs
Researchers Develop New Class of Lung Cancer Drugs
BioSpace
lung cancer
KRAS inhibitors
Institute of Cancer Research
drug development
Flag link:
In U.S. Biosimilars Run Into More Roadblocks
In U.S. Biosimilars Run Into More Roadblocks
Forbes
biosimilars
drug development
Flag link:
Citing phase 2 figures, Axon looks for big pharma investment for Alzheimer’s vaccine
Citing phase 2 figures, Axon looks for big pharma investment for Alzheimer’s vaccine
Pharmaforum
Alzheimer's disease
drug development
vaccines
Axon
Flag link:
New $17M Johns Hopkins research center to study psychedelic drugs in Alzheimer's, addiction and more
New $17M Johns Hopkins research center to study psychedelic drugs in Alzheimer's, addiction and more
Fierce Biotech
psychedelic drugs
Johns Hopkins
drug development
Alzheimer's disease
addiction
Flag link:
FDA's new guidance on heart failure could change the way we treat patients and develop drugs
FDA's new guidance on heart failure could change the way we treat patients and develop drugs
The Hill
FDA
heart failure
drug development
Flag link:
Celgene Adds Cell Therapies From Immatics With Bristol Sale in Sight
Celgene Adds Cell Therapies From Immatics With Bristol Sale in Sight
Xconomy
Celgene
cell therapies
drug development
Immatics
cancer
Flag link:
Bristol-Myers opens up the Phase 0 pathway in testing its new cancer therapies, following in Celgene’s footsteps
Bristol-Myers opens up the Phase 0 pathway in testing its new cancer therapies, following in Celgene’s footsteps
Endpoints
Bristol-Myers Squibb
Celgene
Presage Biosciences
Phase 0 testing
drug development
Flag link:
Scorpion Venom Could Provide Clue into Non-Opioid Treatments for Chronic Pain
Scorpion Venom Could Provide Clue into Non-Opioid Treatments for Chronic Pain
BioSpace
painkillers
opioids
non-opioid pain treatments
drug development
Flag link:
BeiGene's first U.S. NDA tests global development strategy
BeiGene's first U.S. NDA tests global development strategy
BioCentury
BeiGene
China
FDA
drug development
zanubrutinib
Flag link:
Can a new Lyme disease vaccine overcome a history of distrust and failure?
Can a new Lyme disease vaccine overcome a history of distrust and failure?
Stat
Lyme disease
vaccines
drug development
LYMErix
VLA15
Valneva
Flag link:
Translating microbiome research into treatments
Translating microbiome research into treatments
Pharmaforum
microbiome
drug development
Flag link:
To Find The Next Antibiotic, Scientists Give Old Drugs A New Purpose
To Find The Next Antibiotic, Scientists Give Old Drugs A New Purpose
NPR
antiobiotics
antibiotic resistance
R&D
drug development
MRSA
Flag link:
CMS prescribes payment fix to resuscitate US antibiotic industry
CMS prescribes payment fix to resuscitate US antibiotic industry
Endpoints
CMS
antibiotics
drug development
Flag link:
5 years later, Ice Bucket Challenge's impact on drug research still unfolding
5 years later, Ice Bucket Challenge's impact on drug research still unfolding
Bizjournals
ALS
fundraising
drug development
Flag link:
FDA’s No. 2 on RWE, Hype and Speeding Drug Development
FDA’s No. 2 on RWE, Hype and Speeding Drug Development
RAPS.org
FDA
RWE
real world evidence
drug development
Flag link:
23andMe and GSK are mining customers’ DNA data in a hunt for new drugs
23andMe and GSK are mining customers’ DNA data in a hunt for new drugs
Marketwatch
23andMe
GSK
data
data mining
DNA
DNA testing
drug development
ethics
Flag link:

Pages